Year-End Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$3,202,411

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Report (this page) Feb 14, 2008 $3,202,411 Replaced
Year-End Amendment Aug 25, 2008 $514,512 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

S.1610, Foreign Investment and National Security Act of 2007 HR 556, National Security Foreign Investment Reform and Strengthened Transparency Act of 2007 Issues relating to Tariff

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: State, Dept of (DOS); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 556 (110th), S. 1610 (110th)

Copyright/Patent/Trademark CPT

S.1145 and HR 1908, Patent Reform Act of 2006 S. 316, The Preserve Access to Affordable Generics Act

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Treasury, Dept of; SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th), S. 316 (110th)

Taxation/Internal Revenue Code TAX

Protocol Amending the Convention Between the United States and Germany for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income and Capital and to Certain Other Taxes (Treaty Doc. 109-20)

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Treasury, Dept of; SENATE

Health Issues HCR

S.1082, FDA Revitalization Act HR 2900, The FDA Amendments Act of 2007 S. 623 and HR 1038, Access to Life Saving Medicines Act S. 1695, Biologics Price Completion and Innovation Act of 2007

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: State, Dept of (DOS); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1695 (110th), S. 623 (110th), H.R. 2900 (110th), S. 1082 (110th), H.R. 1038 (110th)

Medicare/Medicaid MMM

S. 3, relating to fair prescription drug prices for Medicare beneficiaries HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 Issues relating to Medicaid rebate

LobbyistCovered position, as disclosed
HENRY W MENN N/A
KRISTEN DW MORRIS N/A

Contacted: State, Dept of (DOS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3 (110th), H.R. 4 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.